In the BioHarmony Drug Report Database

"Preview" Icon

Entecavir

Baraclude (entecavir) is a small molecule pharmaceutical. Entecavir was first approved as Baraclude on 2005-03-29. It is used to treat chronic hepatitis b and hepatitis b in the USA. It has been approved in Europe to treat chronic hepatitis b and hepatitis b.

 

Trade Name

 

Baraclude
 

Common Name

 

entecavir
 

ChEMBL ID

 

CHEMBL713
 

Indication

 

chronic hepatitis b, hepatitis b
 

Drug Class

 

Antivirals: carbocyclic nucleosides

Image (chem structure or protein)

Entecavir structure rendering